… Intravesical therapy with bacillus Calmette-Guerin (BCG) has proved to be more effective in
the prophylaxis and treatment of … in situ than most chemotherapeutic agents. Compared to …

… by the experience of our group with intravesical therapy, the unspecific supportive measures
or the detailed information on the treatment given to the patient when obtaining informed …

… intravesical treatment with bacillus Calmette–Guérin (… intravesical BCG are lacking and
severe complications are usually described in case reports only. All physicians giving intravesical …

… Although we had expected a higher placebo response rate with intravesical therapy, our
low placebo response is consistent with prior studies of oral therapies for IC and this should be …

… treatment for intermediate- and high-risk patients is a transurethral resection followed by
intravesical therapy with bacillus Calmette-Guerin (BCG… This therapy, although shown to reduce …

… for CIS is radical cystectomy or conservative intravesical instillations remains unclear. …
treatment options. Thus, this meta-analysis only deals with the conservative intravesical treatment …

… Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for
… bladder cancer to a second course of intravesical bacillus Calmette-Guerin. J Urul 1990: …

… Most urologists favor adjuvant treatment after TUR of all visible lesions. Intravesical bacille
Calmette-Guérin (BCG) appears to be the most effective agent for superficial bladder cancer …

… of the use of intravesical bacillus Calmette-Guerin (BCG) in the treatment of interstitial cystitis
… We now report the long-term followup results of those patients who received intravesical …

… In this study, we found that bladder-sparing therapies achieved modest efficacy in patients
with non–muscle-invasive bladder cancer after bacillus Calmette-Guérin (BCG). These results …